|
DOXECITINE
 INN DOXECITINE
|
cas 951-77-9 |
CLASS METABOLISM PYRIMIDINE NUCLEOSIDE TREATMENT OF THYMIDINE KINASE 2 DEFICIENCY (TK2D) INCORPORATED INTO SKELETAL MUSCLE MITOCHONDRIAL DEOXYRIBONUCLEIC ACID (DNA) |
|
ATC code
A16AX29 |
PK parameters Tmax 2 HOUR PPB 10 PERCENT t1/2 1 HOUR
|
Target TARGET DNA |
DrugCentral - |
Download SDF file |
Cytidine, 2-deoxy- Formula: C9H13N3O4 Calculated chemical properties: MW 227.22 NB_atoms 16 XLogP -1.53 PSA 105.781 NB_HD 4 NB_HA 7 fsp3 0.56 Lipinski(0=no;1=yes) 1 |
FDA NDA 219792 ( label) INN (DOXECITINE ; DOXRIBTIMINE) KYGEVVI (UCB INC) APPROVAL= AP YEAR= 2025 NEWMOLECULARENTITY |
Other links: PubChem ChemicalProbes U.S. repository of Clinical Trials VigiAccess SIDER side effects ChemSynthesis Patent@SureChEMBL |